Market EventĀ·Ā·4 min readĀ·Data as of May 18, 2026

ALAB Is Down 14%. What History Says About This Drop

Share

Astera Labs, Inc. (ALAB) has reached a drawdown of 14.4% as of May 18, 2026, marking a shift from its previous green zone status into the yellow zone. This decline has persisted for 182 days since the stock reached its all-time high of $251.88. Our data shows that this movement represents a significant departure from the asset's typical price behavior.

Drawdown Severity Scoreā„¢

Down 14% over 182 days. This pullback is above average but not extreme by historical standards.

2.16

Moderately Elevated
0510+

Price

$215.58

All-Time High

$251.88

Drawdown

-14.4%

Duration

182 days

What is the Drawdown Severity Scoreā„¢?

Current Drawdown Severity Analysis

The Drawdown Severity Scoreā„¢ for Astera Labs, Inc. (ALAB) currently stands at 2.2. This score classifies the stock in the Moderately Elevated category. This transition into the yellow zone indicates that the current price action is no longer considered a routine fluctuation.

Our data indicates that the current 14.4% drawdown has already exceeded the historical average max drawdown of 13.3% for this asset. While the stock has experienced 15 total drawdown events in its recorded history, the current duration of 182 days is substantially longer than the average drawdown duration of 34 days. This suggests a more prolonged period of price pressure than what is typically observed for this stock.

Historical Comparison and Duration

In the history of Astera Labs, Inc. (ALAB), we have recorded only 3 times where the stock dropped 20% or more. The average duration of these comparable drops was 148 days. It is important to note that the current drawdown has already lasted 182 days, which exceeds the average duration of those more severe historical events.

ALAB Drawdown History

Percentage below all-time high over time

Now

-14.4%

When evaluating these historical comparisons, we must note the small sample size. With only 3 comparable events of 20% or greater, the statistical averages may be subject to higher variance. However, the Drawdown Severity Scoreā„¢ of 2.2 reflects the fact that the current price level of $215.58 is testing historical support levels established during previous pullbacks.

Analyzing the Severity Thresholds

The Drawdown Severity Scoreā„¢ provides a framework for understanding risk by comparing the current decline to the asset's own volatility profile. A score of 2.2 places Astera Labs, Inc. (ALAB) in a position where the drawdown is deeper and longer than 70% of its historical pullbacks.

What History Says

ALAB has dropped 20%+ from its high 3 times in its tracked history.

Occurrences

3

Avg Duration

148

days

Avg Max Drop

-48.5%

PeriodMax DropDuration
Dec 2024 to Aug 2025-63.7%222 days
Apr 2024 to Nov 2024-57.6%190 days
Mar 2024 to Apr 2024-24.1%32 days

View ALAB's full drawdown history →

Our data shows that when the severity score enters the yellow zone, the time to recovery often extends beyond the initial expectations set by shorter, green-zone fluctuations. The 182-day duration of the current drawdown is currently the primary factor influencing the elevated Drawdown Severity Scoreā„¢.

Data Scope and Methodology

This analysis relies exclusively on verified price, drawdown, severity, and duration data as of May 18, 2026. We use the asset's price history and historical drawdown events to calculate the Drawdown Severity Scoreā„¢. This report does not incorporate external market factors, corporate developments, or broader economic indicators.

The findings presented here are based on the 15 historical drawdown events recorded for Astera Labs, Inc. (ALAB). We do not make causal claims regarding the reasons for the price movement. Our data serves to provide historical context for the current 14.4% decline relative to past performance.

What to Watch in the Drawdown Cycle

Investors monitoring Astera Labs, Inc. (ALAB) should observe several specific data markers. First, a further decline toward the 20% drawdown level would align this event with the 3 most severe pullbacks in the stock's history. Second, the Drawdown Severity Scoreā„¢ will continue to adjust based on whether the stock finds price support at the current $215.58 level or continues its 182-day slide.

A shift back toward the green zone would require a sustained move toward the all-time high of $251.88. Conversely, if the duration continues to increase without a price recovery, the Drawdown Severity Scoreā„¢ may climb higher within the yellow zone, indicating increased risk relative to historical norms.

Track ALAB's Drawdown Severity Scoreā„¢

Set a custom alert and get notified when ALAB crosses into a new severity zone.

Get Started Free

Get the weekly drawdown digest

A weekly summary of fresh drawdown analysis, market severity changes, and watchlist setup ideas. No per-article blasts.

Share

Frequently Asked Questions

How far has ALAB fallen from its all-time high?

Astera Labs has fallen 14.4% from its all-time high of $251.88. This decline has persisted for 182 days as the stock price moved to $215.58. This movement represents a significant departure from the typical price behavior for this asset.

What is ALAB's drawdown?

The stock currently has a drawdown severity score of 2.2, which places it in the Moderately Elevated category. This transition into the yellow zone indicates that the current price action is no longer considered a routine fluctuation. Historically, this score reflects that the stock is testing support levels established during previous pullbacks.

How long has ALAB been in a drawdown?

ALAB has been in a drawdown for 182 days, which is substantially longer than its historical average duration of 34 days. Even when compared to more severe historical drops of 20% or more, which averaged 148 days, the current period of price pressure has lasted longer. This suggests a more prolonged recovery period than what is typically observed for this stock.

Disclaimer: DrawdownAlerts provides historical data analysis, not financial advice. Past performance does not guarantee future results. Severity scores are analytical tools, not buy/sell signals. Always do your own research before making investment decisions.